Motion Acquisition (DCGO)
(Real Time Quote from BATS)
$3.48 USD
+0.09 (2.66%)
Updated May 2, 2024 03:10 PM ET
4-Sell of 5 4
B Value F Growth C Momentum D VGM
DocGo Inc. (DCGO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$9.67 | $12.00 | $6.50 | 185.25% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for DocGo Inc. comes to $9.67. The forecasts range from a low of $6.50 to a high of $12.00. The average price target represents an increase of 185.25% from the last closing price of $3.39.
Analyst Price Targets (7 )
Broker Rating
DocGo Inc. currently has an average brokerage recommendation (ABR) of 1.14 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.14 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 85.71% and 14.29% of all recommendations. A month ago, Strong Buy made up 85.71%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 6 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.14 | 1.14 | 1.14 | 1.14 | 1.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/10/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
2/29/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
2/29/2024 | Canaccord Genuity | Richard Close | Strong Buy | Strong Buy |
2/29/2024 | Needham & Company | Ryan Macdonald | Moderate Buy | Moderate Buy |
1/2/2024 | Northland Capital Markets | Michael J Latimore | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.14 |
ABR (Last week) | 1.14 |
# of Recs in ABR | 7 |
Average Target Price | $9.67 |
LT Growth Rate | 28.10% |
Industry | Medical Services |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | 0.09 |